Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2004 Jul;41(7):492–507. doi: 10.1136/jmg.2003.015867

Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation

V Abkevich 1, A Zharkikh 1, A Deffenbaugh 1, D Frank 1, Y Chen 1, D Shattuck 1, M Skolnick 1, A Gutin 1, S Tavtigian 1
PMCID: PMC1735826  PMID: 15235020

Abstract

Introduction: Interpretation of results from mutation screening of tumour suppressor genes known to harbour high risk susceptibility mutations, such as APC, BRCA1, BRCA2, MLH1, MSH2, TP53, and PTEN, is becoming an increasingly important part of clinical practice. Interpretation of truncating mutations, gene rearrangements, and obvious splice junction mutations, is generally straightforward. However, classification of missense variants often presents a difficult problem. From a series of 20 000 full sequence tests of BRCA1 carried out at Myriad Genetic Laboratories, a total of 314 different missense changes and eight in-frame deletions were observed. Before this study, only 21 of these missense changes were classified as deleterious or suspected deleterious and 14 as neutral or of little clinical significance.

Methods: We have used a combination of a multiple sequence alignment of orthologous BRCA1 sequences and a measure of the chemical difference between the amino acids present at individual residues in the sequence alignment to classify missense variants and in-frame deletions detected during mutation screening of BRCA1.

Results: In the present analysis we were able to classify an additional 50 missense variants and two in-frame deletions as probably deleterious and 92 missense variants as probably neutral. Thus we have tentatively classified about 50% of the unclassified missense variants observed during clinical testing of BRCA1.

Discussion: An internal test of the analysis is consistent with our classification of the variants designated probably deleterious; however, we must stress that this classification is tentative and does not have sufficient independent confirmation to serve as a clinically applicable stand alone method.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altschul S. F., Gish W., Miller W., Myers E. W., Lipman D. J. Basic local alignment search tool. J Mol Biol. 1990 Oct 5;215(3):403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  2. Aparicio Samuel, Chapman Jarrod, Stupka Elia, Putnam Nik, Chia Jer-Ming, Dehal Paramvir, Christoffels Alan, Rash Sam, Hoon Shawn, Smit Arian. Whole-genome shotgun assembly and analysis of the genome of Fugu rubripes. Science. 2002 Jul 25;297(5585):1301–1310. doi: 10.1126/science.1072104. [DOI] [PubMed] [Google Scholar]
  3. Beaudet A. L., Tsui L. C. A suggested nomenclature for designating mutations. Hum Mutat. 1993;2(4):245–248. doi: 10.1002/humu.1380020402. [DOI] [PubMed] [Google Scholar]
  4. Benner S. A., Cohen M. A., Gonnet G. H. Amino acid substitution during functionally constrained divergent evolution of protein sequences. Protein Eng. 1994 Nov;7(11):1323–1332. doi: 10.1093/protein/7.11.1323. [DOI] [PubMed] [Google Scholar]
  5. Boguski MS, Cox DR, Myers RM. Genomes and evolution. Curr Opin Genet Dev. 1996 Dec 1;6(6):683–685. doi: 10.1016/s0959-437x(96)80020-7. [DOI] [PubMed] [Google Scholar]
  6. Boyd M., Harris F., McFarlane R., Davidson H. R., Black D. M. A human BRCA1 gene knockout. Nature. 1995 Jun 15;375(6532):541–542. doi: 10.1038/375541b0. [DOI] [PubMed] [Google Scholar]
  7. Brieger A., Trojan J., Raedle J., Plotz G., Zeuzem S. Transient mismatch repair gene transfection for functional analysis of genetic hMLH1 and hMSH2 variants. Gut. 2002 Nov;51(5):677–684. doi: 10.1136/gut.51.5.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Campbell I. G., Schroff R., Englefield P., Eccles D. M. BRCA1 polymorphisms. Br J Cancer. 1997;75(12):1854–1855. doi: 10.1038/bjc.1997.318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chasman D., Adams R. M. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: structure-based assessment of amino acid variation. J Mol Biol. 2001 Mar 23;307(2):683–706. doi: 10.1006/jmbi.2001.4510. [DOI] [PubMed] [Google Scholar]
  10. Chen C. F., Li S., Chen Y., Chen P. L., Sharp Z. D., Lee W. H. The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem. 1996 Dec 20;271(51):32863–32868. doi: 10.1074/jbc.271.51.32863. [DOI] [PubMed] [Google Scholar]
  11. Deffenbaugh Amie M., Frank Thomas S., Hoffman Michael, Cannon-Albright Lisa, Neuhausen Susan L. Characterization of common BRCA1 and BRCA2 variants. Genet Test. 2002 Summer;6(2):119–121. doi: 10.1089/10906570260199375. [DOI] [PubMed] [Google Scholar]
  12. Fairbrother William G., Yeh Ru-Fang, Sharp Phillip A., Burge Christopher B. Predictive identification of exonic splicing enhancers in human genes. Science. 2002 Jul 11;297(5583):1007–1013. doi: 10.1126/science.1073774. [DOI] [PubMed] [Google Scholar]
  13. Ferrer-Costa Carles, Orozco Modesto, de la Cruz Xavier. Characterization of disease-associated single amino acid polymorphisms in terms of sequence and structure properties. J Mol Biol. 2002 Jan 25;315(4):771–786. doi: 10.1006/jmbi.2001.5255. [DOI] [PubMed] [Google Scholar]
  14. Fitch W. M., Markowitz E. An improved method for determining codon variability in a gene and its application to the rate of fixation of mutations in evolution. Biochem Genet. 1970 Oct;4(5):579–593. doi: 10.1007/BF00486096. [DOI] [PubMed] [Google Scholar]
  15. Flaman J. M., Frebourg T., Moreau V., Charbonnier F., Martin C., Chappuis P., Sappino A. P., Limacher I. M., Bron L., Benhattar J. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3963–3967. doi: 10.1073/pnas.92.9.3963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fleming Melissa A., Potter John D., Ramirez Christina J., Ostrander Gary K., Ostrander Elaine A. Understanding missense mutations in the BRCA1 gene: an evolutionary approach. Proc Natl Acad Sci U S A. 2003 Jan 16;100(3):1151–1156. doi: 10.1073/pnas.0237285100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frank T. S., Manley S. A., Olopade O. I., Cummings S., Garber J. E., Bernhardt B., Antman K., Russo D., Wood M. E., Mullineau L. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998 Jul;16(7):2417–2425. doi: 10.1200/JCO.1998.16.7.2417. [DOI] [PubMed] [Google Scholar]
  18. Futreal P. A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K., Tavtigian S., Bennett L. M., Haugen-Strano A., Swensen J., Miki Y. BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994 Oct 7;266(5182):120–122. doi: 10.1126/science.7939630. [DOI] [PubMed] [Google Scholar]
  19. Goodman M., Porter C. A., Czelusniak J., Page S. L., Schneider H., Shoshani J., Gunnell G., Groves C. P. Toward a phylogenetic classification of Primates based on DNA evidence complemented by fossil evidence. Mol Phylogenet Evol. 1998 Jun;9(3):585–598. doi: 10.1006/mpev.1998.0495. [DOI] [PubMed] [Google Scholar]
  20. Gowen L. C., Johnson B. L., Latour A. M., Sulik K. K., Koller B. H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet. 1996 Feb;12(2):191–194. doi: 10.1038/ng0296-191. [DOI] [PubMed] [Google Scholar]
  21. Grantham R. Amino acid difference formula to help explain protein evolution. Science. 1974 Sep 6;185(4154):862–864. doi: 10.1126/science.185.4154.862. [DOI] [PubMed] [Google Scholar]
  22. Hakem R., de la Pompa J. L., Sirard C., Mo R., Woo M., Hakem A., Wakeham A., Potter J., Reitmair A., Billia F. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 1996 Jun 28;85(7):1009–1023. doi: 10.1016/s0092-8674(00)81302-1. [DOI] [PubMed] [Google Scholar]
  23. Hartge P., Struewing J. P., Wacholder S., Brody L. C., Tucker M. A. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet. 1999 Apr;64(4):963–970. doi: 10.1086/302320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hohenstein P., Kielman M. F., Breukel C., Bennett L. M., Wiseman R., Krimpenfort P., Cornelisse C., van Ommen G. J., Devilee P., Fodde R. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage. Oncogene. 2001 May 3;20(20):2544–2550. doi: 10.1038/sj.onc.1204363. [DOI] [PubMed] [Google Scholar]
  25. Hu Y. F., Miyake T., Ye Q., Li R. Characterization of a novel trans-activation domain of BRCA1 that functions in concert with the BRCA1 C-terminal (BRCT) domain. J Biol Chem. 2000 Dec 29;275(52):40910–40915. doi: 10.1074/jbc.C000607200. [DOI] [PubMed] [Google Scholar]
  26. Huchon Dorothée, Madsen Ole, Sibbald Mark J. J. B., Ament Kai, Stanhope Michael J., Catzeflis François, de Jong Wilfried W., Douzery Emmanuel J. P. Rodent phylogeny and a timescale for the evolution of Glires: evidence from an extensive taxon sampling using three nuclear genes. Mol Biol Evol. 2002 Jul;19(7):1053–1065. doi: 10.1093/oxfordjournals.molbev.a004164. [DOI] [PubMed] [Google Scholar]
  27. Ishioka C., Frebourg T., Yan Y. X., Vidal M., Friend S. H., Schmidt S., Iggo R. Screening patients for heterozygous p53 mutations using a functional assay in yeast. Nat Genet. 1993 Oct;5(2):124–129. doi: 10.1038/ng1093-124. [DOI] [PubMed] [Google Scholar]
  28. Joukov V., Chen J., Fox E. A., Green J. B., Livingston D. M. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc Natl Acad Sci U S A. 2001 Oct 2;98(21):12078–12083. doi: 10.1073/pnas.211427098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jukes T. H., King J. L. Deleterious mutations and neutral substitutions. Nature. 1971 May 14;231(5298):114–115. doi: 10.1038/231114a0. [DOI] [PubMed] [Google Scholar]
  30. Koonin E. V., Altschul S. F., Bork P. BRCA1 protein products ... Functional motifs... Nat Genet. 1996 Jul;13(3):266–268. doi: 10.1038/ng0796-266. [DOI] [PubMed] [Google Scholar]
  31. Kuschel B., Gayther S. A., Easton D. F., Ponder B. A., Pharoah P. D. Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: implications for genetic testing. Genes Chromosomes Cancer. 2001 May;31(1):96–98. doi: 10.1002/gcc.1122. [DOI] [PubMed] [Google Scholar]
  32. Liu C. Y., Flesken-Nikitin A., Li S., Zeng Y., Lee W. H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 1996 Jul 15;10(14):1835–1843. doi: 10.1101/gad.10.14.1835. [DOI] [PubMed] [Google Scholar]
  33. Ludwig T., Chapman D. L., Papaioannou V. E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 1997 May 15;11(10):1226–1241. doi: 10.1101/gad.11.10.1226. [DOI] [PubMed] [Google Scholar]
  34. Ludwig T., Fisher P., Ganesan S., Efstratiadis A. Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev. 2001 May 15;15(10):1188–1193. doi: 10.1101/gad.879201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Markowitz E. Estimation and testing goodness-of-fit for some models of codon fixation variability. Biochem Genet. 1970 Oct;4(5):595–601. doi: 10.1007/BF00486097. [DOI] [PubMed] [Google Scholar]
  36. Miller M. P., Kumar S. Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet. 2001 Oct 1;10(21):2319–2328. doi: 10.1093/hmg/10.21.2319. [DOI] [PubMed] [Google Scholar]
  37. Miyamoto M. M., Fitch W. M. Testing the covarion hypothesis of molecular evolution. Mol Biol Evol. 1995 May;12(3):503–513. doi: 10.1093/oxfordjournals.molbev.a040224. [DOI] [PubMed] [Google Scholar]
  38. Murphy W. J., Eizirik E., O'Brien S. J., Madsen O., Scally M., Douady C. J., Teeling E., Ryder O. A., Stanhope M. J., de Jong W. W. Resolution of the early placental mammal radiation using Bayesian phylogenetics. Science. 2001 Dec 14;294(5550):2348–2351. doi: 10.1126/science.1067179. [DOI] [PubMed] [Google Scholar]
  39. Ng Pauline C., Henikoff Steven. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 2002 Mar;12(3):436–446. doi: 10.1101/gr.212802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Notredame C., Higgins D. G., Heringa J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol. 2000 Sep 8;302(1):205–217. doi: 10.1006/jmbi.2000.4042. [DOI] [PubMed] [Google Scholar]
  41. Nyström-Lahti Minna, Perrera Claudia, Räschle Markus, Panyushkina-Seiler Elena, Marra Giancarlo, Curci Anna, Quaresima Barbara, Costanzo Francesco, D'Urso Michele, Venuta Salvatore. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer. 2002 Feb;33(2):160–167. [PubMed] [Google Scholar]
  42. Orelli B. J., Logsdon Jr J. M., Jr, Bishop D. K. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue. Oncogene. 2001 Jul 19;20(32):4433–4438. doi: 10.1038/sj.onc.1204485. [DOI] [PubMed] [Google Scholar]
  43. Panguluri R. C., Brody L. C., Modali R., Utley K., Adams-Campbell L., Day A. A., Whitfield-Broome C., Dunston G. M. BRCA1 mutations in African Americans. Hum Genet. 1999 Jul-Aug;105(1-2):28–31. doi: 10.1007/s004399900085. [DOI] [PubMed] [Google Scholar]
  44. Satagopan J. M., Offit K., Foulkes W., Robson M. E., Wacholder S., Eng C. M., Karp S. E., Begg C. B. The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):467–473. [PubMed] [Google Scholar]
  45. Shattuck-Eidens D., Oliphant A., McClure M., McBride C., Gupte J., Rubano T., Pruss D., Tavtigian S. V., Teng D. H., Adey N. BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA. 1997 Oct 15;278(15):1242–1250. [PubMed] [Google Scholar]
  46. Szabo C. I., Wagner L. A., Francisco L. V., Roach J. C., Argonza R., King M. C., Ostrander E. A. Human, canine and murine BRCA1 genes: sequence comparison among species. Hum Mol Genet. 1996 Sep;5(9):1289–1298. doi: 10.1093/hmg/5.9.1289. [DOI] [PubMed] [Google Scholar]
  47. Tang N. L., Pang C. P., Yeo W., Choy K. W., Lam P. K., Suen M., Law L. K., King W. W., Johnson P., Hjelm M. Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst. 1999 May 19;91(10):882–885. doi: 10.1093/jnci/91.10.882. [DOI] [PubMed] [Google Scholar]
  48. Thakur S., Zhang H. B., Peng Y., Le H., Carroll B., Ward T., Yao J., Farid L. M., Couch F. J., Wilson R. B. Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol. 1997 Jan;17(1):444–452. doi: 10.1128/mcb.17.1.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Vallon-Christersson J., Cayanan C., Haraldsson K., Loman N., Bergthorsson J. T., Brøndum-Nielsen K., Gerdes A. M., Møller P., Kristoffersson U., Olsson H. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet. 2001 Feb 15;10(4):353–360. doi: 10.1093/hmg/10.4.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Vega A., Campos B., Bressac-De-Paillerets B., Bond P. M., Janin N., Douglas F. S., Domènech M., Baena M., Pericay C., Alonso C. The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript. Hum Mutat. 2001 Jun;17(6):520–521. doi: 10.1002/humu.1136. [DOI] [PubMed] [Google Scholar]
  51. Zuckerkandl E., Pauling L. Molecules as documents of evolutionary history. J Theor Biol. 1965 Mar;8(2):357–366. doi: 10.1016/0022-5193(65)90083-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES